Literature DB >> 8430356

Virucides in prevention of HIV infection. Research Priorities. World Health Organization Working Group on Virucides.

M J Rosenberg1, K K Holmes.   

Abstract

Vaginal spermicides have microbicidal properties that suggest their usefulness in helping to protect against human immunodeficiency virus (HIV) and other sexually transmitted infections. Laboratory, animal, and clinical investigations also support this notion. Because of the importance of identifying additional methods to protect against these infections, however, better information is needed on these female-controlled methods. A consistent set of laboratory standards is needed to evaluate the in vitro activity of existing and future virucides. Further evaluation of such areas as the actions of virucides and vehicles on different anatomical sites and safety studies to better judge determinants of toxicity are needed. Clinical studies might compare efficacy of spermicides and condoms in prevention of HIV and other sexually transmitted diseases as well as investigate psychosocial considerations that determine suitable candidates for vaginal virucides, how they are used, and how their use might be improved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430356     DOI: 10.1097/00007435-199301000-00008

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

1.  The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.

Authors:  P B Wyrick; S T Knight; D G Gerbig; J E Raulston; C H Davis; T R Paul; D Malamud
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

2.  Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

Authors:  M R Boyd; K R Gustafson; J B McMahon; R H Shoemaker; B R O'Keefe; T Mori; R J Gulakowski; L Wu; M I Rivera; C M Laurencot; M J Currens; J H Cardellina; R W Buckheit; P L Nara; L K Pannell; R C Sowder; L E Henderson
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 3.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

4.  Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro.

Authors:  H Thormar; G Bergsson; E Gunnarsson; G Georgsson; M Witvrouw; O Steingrímsson; E De Clercq; T Kristmundsdóttir
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

5.  In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides.

Authors:  G Bergsson; J Arnfinnsson; S M Karlsson; O Steingrímsson; H Thormar
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.